Skip to content
DataLookout
Menu

NCT07229807

Efficacy and Safety of ZSP1273 in Children 2-11 Years Old With Influenza A

StatusCompleted
PhasePhase 3
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 13 words Show 4 more changesShow less
    • Trial completed
    • Primary completion date changed from estimate of Dec 17, 2025 to Jan 17, 2026
    • Enrollment target: estimated 119 to confirmed 120
    • Study completion date changed from estimate of Dec 31, 2025 to Jan 21, 2026
  2. Minor Trial status: Not Yet Recruiting to Active, Not Recruitingv3 Show 5 more changesShow less
    • Enrollment target: 114 to 119
    • Primary completion date: Jun 17, 2026 to Dec 17, 2025
    • Study completion date: Sep 17, 2026 to Dec 31, 2025
    • Start date changed from estimate of Nov 30, 2025 to Nov 22, 2025
    • Site contact updated
  3. Minor Secondary endpoints: details revised at 1 of 2 entriesv2
  4. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Time to Alleviation of Symptoms
Timeframe: DAY1~DAY15

Secondary (2)

Plasma concentrations of ZSP1273
Number of participants with treatment-related adverse events as assessed by CTCAE v5.0

Arms and interventions

ZSP1273Experimental
OseltamivirActive comparator

Drugs: ZSP1273, Oseltamivir

Sites

1 site in 1 country

  • Beijing Children HospitalBeijing, China